News

 

At AseBio, we follow the latest news in the biotechnology sector and pass the highlights on to you. You can use the search engine to find news articles we’ve written, contributed by our members or from other stakeholders in the sector. And they are also organised into categories to help you find the topics you’re interested in easily.

Search engine
Shilpa Biocare invierte en Gate2Brain para impulsar G2B-002, un innovador candidato terapéutico para el cáncer cerebral
Shilpa Biocare Invests in Gate2Brain to Advance G2B-002, an Innovative Brain Cancer Therapeutic Candidate
Healthcare · Rare diseases · Innovative drugs
Gate2Brain signs a strategic partnership with Shilpa Biocare, including a €7 million investment for…
Partners - Gate2Brain
Unión Europea
AseBio is involved in three key European initiatives aimed at boosting biotechnology competitiveness and scaling
Industrial biotechnology · International · Financing
We have contributed to the Fraunhofer Institute’s technical questionnaire on the Biotech Act II,…
El Parc Científic de la Universidad de Barcelona alcanza una inversión histórica de 230 millones de euros en 2025
The University of Barcelona Science Park reaches a new investment record of €230 million in 2025
Healthcare · Innovative drugs · Financing
The University of Barcelona Parc Científic de Barcelona (PCB-UB) broke its investment record in…
Partners - Parc Científic de Barcelona
LOGO STABLEPHARMA
Stablepharma and AFT Move to Expand Fridge-Free Vaccine Distribution Following Positive Clinical Data
Healthcare · Innovative drugs · International
Potential agreement follows positive clinical and stability data, supporting rollout in UK, Canada…
Partners - STABLEPHARMA
ORYZON Presents Updated Positive Clinical Data for Iadademstat in Acute Myeloid Leukemia (AML) at European Hematology Association (EHA) 2026 Annual Congress
ORYZON Presents Updated Positive Clinical Data for Iadademstat in Acute Myeloid Leukemia (AML) at European Hematology Association (EHA) 2026 Annual Congress
Healthcare · Drug discovery · Innovative drugs
In first line AML (ALICE-2 trial), iadademstat with azacitidine and venetoclax showed high levels…
Partners - Oryzon Genomics
Joan Martí – Director de Estrategia Empresarial en ACCIÓ
Joan Martí: “Corporate culture is a critical factor in M&A and partnership processes”
Financing · Corporate
Joan Martí is Director of Business Strategy at ACCIÓ, the Agency for Business Competitiveness of…
Partners - GENESIS Biomed
Presentación del Informe AseBio 2025
Biotech sector reaches record investment levels, surpassing €400 million
Corporate
Investment in R&D by the biotechnology sector increased by 13.9%, reaching €1.46 billion.
VIVEbiotech amplía su cartera con nuevos programas terapéuticos basados en vectores lentivirales in vivo
VIVEbiotech adds newest in vivo lentiviral vector-based therapeutic programs
Healthcare · Innovative drugs · Advanced therapies
Now advancing 15 next-generation in vivo therapies through high performance, scalable lentiviral…
Partners - VIVEbiotech
Juan Bueren
Juan Bueren will share at BIOSPAIN 2026 the key insights on how to turn research into life-changing gene therapies
Advanced therapies · International · BioSpain
Juan Bueren will be one of the keynote speakers at BIOSPAIN 2026, held in Bilbao from September 29…